MMPs as therapeutic targets—still a viable option?

B Fingleton - Seminars in cell & developmental biology, 2008 - Elsevier
Matrix metalloproteinases (MMPs) appear to be ideal drug targets—they are disease-
associated, extracellular enzymes with a dependence on zinc for activity. This apparently …

Matrix metalloproteinases as valid clinical target

B Fingleton - Current pharmaceutical design, 2007 - ingentaconnect.com
The matrix metalloproteinase family of enzymes has been a pharmaceutical target for over
20 years. In that time, many drugs have been developed but none have successfully passed …

Metabolic Intervention Nanoparticles for Triple‐Negative Breast Cancer Therapy via Overcoming FSP1‐Mediated Ferroptosis Resistance

J Yang, Z Jia, J Zhang, X Pan, Y Wei… - Advanced …, 2022 - Wiley Online Library
Triple‐negative breast cancer (TNBC) patients have a predisposition to poor prognosis due
to the strong malignancy. Ferroptosis, a new form of cell death, is a candidate treatment for …

[HTML][HTML] Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth

O Schouten, JHH van Laanen, E Boersma… - European journal of …, 2006 - Elsevier
OBJECTIVE: To evaluate the effect of statins on aneurysm growth in a group of consecutive
patients under surveillance for infrarenal aortic aneurysms (AAA). MATERIALS AND …

Pharmacologic management of aneurysms

JH Lindeman, JS Matsumura - Circulation research, 2019 - Am Heart Assoc
Current management of aortic aneurysms relies exclusively on prophylactic operative repair
of larger aneurysms. Great potential exists for successful medical therapy that halts or …

Association of statin prescription with small abdominal aortic aneurysm progression

CD Ferguson, P Clancy, B Bourke, PJ Walker… - American heart …, 2010 - Elsevier
BACKGROUND: Statins have been suggested to reduce expansion of abdominal aortic
aneurysms (AAAs) independent of lipid-lowering effects. METHODS: We assessed the …

MMPs and ADAMs/ADAMTS inhibition therapy of abdominal aortic aneurysm

Y Li, W Wang, L Li, RA Khalil - Life sciences, 2020 - Elsevier
Abdominal aortic aneurysm (AAA) is a chronic vascular degenerative disease featured by
progressive dilation and remodeling of the vascular wall, which may lead to aortic rupture …

Systematic review and meta-analysis of the effects of statin therapy on abdominal aortic aneurysms

CP Twine, IM Williams - Journal of British Surgery, 2011 - academic.oup.com
Background The aim was to investigate the effects of statin therapy on abdominal aortic
aneurysm (AAA) disease. Methods PubMed, the Cochrane Library, Embase and …

Proteinase systems and thoracic aortic aneurysm progression

JR Barbour, FG Spinale, JS Ikonomidis - Journal of Surgical Research, 2007 - Elsevier
Thoracic aortic aneurysms (TAAs) are a rare but potentially devastating condition. Current
surgical treatment of TAAs usually involves a major operation, which conveys many risks to …

Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ageing: molecular mechanisms

A Bahrami, S Bo, T Jamialahmadi, A Sahebkar - Ageing Research Reviews, 2020 - Elsevier
Human ageing is determined by degenerative alterations and processes with different
manifestations such as gradual organ dysfunction, tissue function loss, increased population …